Timp-2 expression in the cytologic evaluation of adenocarcinoma pleural effusions Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006
Malignant pleural effusion cells show aberrant glucose metabolism gene expression Source: Eur Respir J 2011; 37: 1453-1465 Year: 2011
Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Evaluation of pleural fluid clot histology in the diagnosis of pleural malignancy Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 50s Year: 2006
Ideal volume sampling in the diagnosis of malignant pleural effusions Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Closed pleural needle biopsy and pleural fluid examination in pathological diagnosis of malignant pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 256s Year: 2003
Utility of significant number of mesothelial cells in tuberculous pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 426s Year: 2004
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006
A comparative study of conventional cytology and cell block method in the diagnosis of malignant pleural effusion. Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018
Closed pleural brushing in the diagnosis of malignant pleural effusions Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008
An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006
Diagnosis of malignant pleural effusions; cytology or biopsy? Source: Eur Respir J 2004; 24: Suppl. 48, 72s Year: 2004
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Medical thoracoscopy- Comparison of pleural biopsy, imprint cytology and cytology of pleural effusion Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions Year: 2019